Afrezza: A Game-Changer for Children with Diabetes
Afrezza is an inhaled form of insulin
MannKind Corporation
Managing blood sugar levels in children with type 1 diabetes has always been a challenge, but a groundbreaking solution may be on the horizon. Afrezza, an inhaled form of insulin, has proven to be as effective as injected insulin in controlling blood sugar levels in children. This innovative approach, already available for adults with diabetes, is now seeking approval for use in children.
Type 1 diabetes, a condition where the body is unable to produce insulin, requires daily insulin injections to regulate blood sugar levels. However, maintaining optimal blood sugar levels can be tricky, especially during mealtimes and after physical activity.
A study led by Michael Haller at the University of Florida explored the efficacy of Afrezza in children aged 4 to 17 with type 1 or type 2 diabetes. The results, presented at the American Diabetes Association meeting, revealed that both inhaled and injected insulin formulations were equally effective in managing blood sugar levels.
According to Haller, the convenience of inhaled insulin could be a game-changer for children with needle phobias or those who struggle with daily injections. While the inhaled version may initially cause coughing, this side effect typically diminishes over time. It is important to note that Afrezza is not recommended for individuals with chronic lung conditions like asthma.
Dr. Kathryn Sumpter from The University of Tennessee Health Science Center believes that inhaled insulin may benefit children who require rapid-acting insulin before meals. However, she emphasizes the precise dosing capabilities of injected insulin, which may be more suitable for young children who need smaller insulin doses.
MannKind Corporation, the manufacturer of Afrezza, is working towards regulatory approval for the use of inhaled insulin in children in the US. This promising development could provide children with diabetes with a new tool to effectively manage their condition.
